title: Mycobacterium avium brain abscess at the initiation of highly active antiretroviral therapy.
authors.affiliation: Unité des Rickettsies CNRS UMR 6020, IFR 48, Faculté de Médecine, 27 Boulevard Jean Moulin, 13385 Marseille Cédex 05, France.
authors.forename: P
authors.initials: P
authors.lastname: Berger
authors.forename: H
authors.initials: H
authors.lastname: Lepidi
authors.forename: M P
authors.initials: MP
authors.lastname: Drogoul-Vey
authors.forename: I
authors.initials: I
authors.lastname: Poizot-Martin
authors.forename: M
authors.initials: M
authors.lastname: Drancourt
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000382:microbiology*; D000328:Adult; D000900:Anti-Bacterial Agents; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects* / Q000379:methods; D000995:Antitubercular Agents / Q000627:therapeutic use; D001922:Brain Abscess / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D016867:Immunocompromised Host; D008297:Male; D009162:Mycobacterium avium / Q000302:isolation & purification*; D015270:Mycobacterium avium-intracellulare Infection / Q000175:diagnosis* / Q000188:drug therapy; D035583:Rare Diseases; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents